In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson Matthey PLC

www.matthey.com

Latest From Johnson Matthey PLC

Immunomedics Dodges Manufacturing Site Specifics In Quest For Cancer Breakthrough Approval

Biotech firm chooses words carefully to wind its way through site inspection findings and CMC review concerns in hopes of winning its first FDA approval for a breakthrough breast cancer treatment.

Quality Manufacturing

Deals In Depth: June/July 2015

Sanofi and Regeneron teamed up in a second major deal, focused on immuno-oncology; after an unsuccessful try at Mylan, Teva bought Allergan's generics business. Between June and July, biopharma companies raised over $10 billion, and device firms more than $1 billion.

BioPharmaceutical Medical Device

Shire boosted by Vyvanse patent ruling

Every little helps. A new ruling on the patents for Shire's top-selling drug Vyvanse will help bolster the company's case that AbbVie's recent takeover offer undervalues the firm.

Deals

F-Star makes Tolga Hassan CFO

Oncology-focused F-Star has appointed Tolga Hassan chief financial officer. Mr Hassan joins F-Star from specialty chemicals company Johnson Matthey where he most recently served as division finance director.

See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register